"After reviewing the most recent scientific literature, the United States Preventive Services Task Force (USPSTF)—a group of epidemiologists, public health officials, and physicians charged with reviewing research and making recommendations on preventive care—published a study that says these drugs can reduce the risk of breast cancer and that doctors should recommend them to their high-risk patients.
This is baby-step trying to encourage more prescribing of these drugs to appropriate women. It adds to a 2002 recommendation saying that women should “talk with their physicians” about taking these drugs to prevent breast cancer. But women didn’t seem to listen. The phrase in the most recent pronouncement about using these drugs for “chemoprevention” is that “use is low.” So I guess the hope is that strengthening the language will get more docs and women to discuss this option for high-risk women."